Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Darifenacin 7.5mg modified-release tablets |
| BNF code | 0704020ACAAAAAA |
| Virtual Therapeutic Moiety | Darifenacin |
| Date identifier became valid | 19 Aug 2020 |
| Previous product identifier | 416110006 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Darifenacin hydrobromide |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 416140008 |
| Strength value numerator | 7.500 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tabletmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Darifenacin 7.5mg modified-release tablets (A A H Pharmaceuticals Ltd) | |
| Darifenacin 7.5mg modified-release tablets (Accord-UK Ltd) | |
| Darifenacin 7.5mg modified-release tablets (Alliance Healthcare (Distribution) Ltd) | |
| Darifenacin 7.5mg modified-release tablets (Aristo Pharma Ltd) | |
| Emselex 7.5mg modified-release tablets (CST Pharma Ltd) | |
| Emselex 7.5mg modified-release tablets (Ethigen Ltd) | |
| Emselex 7.5mg modified-release tablets (pharmaand GmbH) | |
| Virtual Medicinal Product Packs | |
| Darifenacin 7.5mg modified-release tablets 28 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_2.0.0_20250203000001, imported on 4th February 2025 at 03:53:58.